Dr. Mercola's Censored Library (Private Membership)

Share this post

New Study Confirms Ivermectin Outperforms Other Options

takecontrol.substack.com

New Study Confirms Ivermectin Outperforms Other Options

Tested on the Omicron variant, ivermectin outperformed 10 medications, including one approved for emergency use. Early treatment can lower hospitalization, mortality and symptoms of long COVID.

Dr. Joseph Mercola
Feb 16, 2022
∙ Paid
22
3
Share
ivermectin outperforms other medications

STORY AT-A-GLANCE

  • Researchers used computational analyses to evaluate the performance of 10 medications against the Omicron variant, finding that ivermectin outperformed all of them, including nirmatrelvir (Paxlovid) a new drug from Pfizer that has cost taxpayers $5.29 billion and costs $529 per course of treatment

  • Ivermectin lowers the viral load by inhi…

Keep reading with a 7-day free trial

Subscribe to Dr. Mercola's Censored Library (Private Membership) to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2023 Dr. Joseph Mercola
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing